__timestamp | Jazz Pharmaceuticals plc | Vertex Pharmaceuticals Incorporated |
---|---|---|
Wednesday, January 1, 2014 | 406114000 | 305409000 |
Thursday, January 1, 2015 | 449119000 | 377080000 |
Friday, January 1, 2016 | 502892000 | 432829000 |
Sunday, January 1, 2017 | 544156000 | 496079000 |
Monday, January 1, 2018 | 683530000 | 557616000 |
Tuesday, January 1, 2019 | 736942000 | 658498000 |
Wednesday, January 1, 2020 | 854233000 | 770456000 |
Friday, January 1, 2021 | 1451683000 | 840100000 |
Saturday, January 1, 2022 | 1416967000 | 944700000 |
Sunday, January 1, 2023 | 1343105000 | 1136600000 |
Monday, January 1, 2024 | 1464300000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, understanding financial trends is crucial. Over the past decade, from 2014 to 2023, Vertex Pharmaceuticals Incorporated and Jazz Pharmaceuticals plc have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. Jazz Pharmaceuticals has consistently outpaced Vertex, with its SG&A expenses peaking at approximately 1.45 billion in 2021, marking a 258% increase from 2014. Meanwhile, Vertex's expenses grew by 272% over the same period, reaching around 1.14 billion in 2023. This growth reflects strategic investments in marketing and administration, crucial for maintaining competitive advantage. Notably, both companies experienced significant expense surges in 2021, likely due to increased operational activities. These trends highlight the dynamic nature of the pharmaceutical industry, where financial agility can be as critical as scientific innovation.
Selling, General, and Administrative Costs: Johnson & Johnson vs Vertex Pharmaceuticals Incorporated
AbbVie Inc. vs Vertex Pharmaceuticals Incorporated: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Amgen Inc. and Vertex Pharmaceuticals Incorporated
Operational Costs Compared: SG&A Analysis of Gilead Sciences, Inc. and Jazz Pharmaceuticals plc
Vertex Pharmaceuticals Incorporated and argenx SE: SG&A Spending Patterns Compared
Vertex Pharmaceuticals Incorporated vs Genmab A/S: SG&A Expense Trends
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs Novavax, Inc. Trends and Insights
Walgreens Boots Alliance, Inc. and Jazz Pharmaceuticals plc: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Pharming Group N.V.
Who Optimizes SG&A Costs Better? Jazz Pharmaceuticals plc or CymaBay Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Arrowhead Pharmaceuticals, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Vericel Corporation Trends and Insights